Structures by: Egert E.
Total: 107
C53H71CoN6O14
C53H71CoN6O14
Acta Crystallographica, Section C: Crystal Structure Communications (1989) 45, 10 1589-1593
a=15.595(2)Å b=18.672(4)Å c=19.023(5)Å
α=90° β=90° γ=90°
Pyrimidine-2,4-diamine
C4H6N4
Acta Crystallographica Section C (2016) 72, 9
a=12.0330(17)Å b=4.0256(3)Å c=11.5992(15)Å
α=90° β=118.346(10)° γ=90°
Pyrimidine-2,4-diamine--1,4-dioxane (2/1)
C4H6N4,0.5(C4H8O2)
Acta Crystallographica Section C (2016) 72, 9
a=7.6282(14)Å b=7.2157(9)Å c=13.879(2)Å
α=90° β=102.243(15)° γ=90°
Pyrimidine-2,4-diamine--<i>N</i>,<i>N</i>-dimethylacetamide (1/1)
C4H6N4,C4H9NO
Acta Crystallographica Section C (2016) 72, 9
a=8.0055(10)Å b=8.0256(10)Å c=9.3143(11)Å
α=81.779(2)° β=78.053(2)° γ=62.518(2)°
2,4-Diaminopyrimidinium barbiturate
C4H7N4,C4H3N2O3
Acta Crystallographica Section C (2016) 72, 9
a=4.6822(7)Å b=15.948(3)Å c=13.514(2)Å
α=90° β=90.240(13)° γ=90°
Pyrimidine-2,4-diamine--1-methylpyrrolidin-2-one (1/1)
C4H6N4,C5H9NO
Acta Crystallographica Section C (2016) 72, 9
a=7.3870(6)Å b=24.8978(13)Å c=11.5485(8)Å
α=90° β=98.824(6)° γ=90°
2,4-Diaminopyrimidinium 2-thiobarbiturate--<i>N</i>,<i>N</i>-dimethylformamide (1/2)
C4H7N4,C4H3N2O2S,2(C3H7NO)
Acta Crystallographica Section C (2016) 72, 9
a=8.0115(9)Å b=19.2213(14)Å c=12.9531(13)Å
α=90° β=90.230(8)° γ=90°
2,4-Diaminopyrimidinium 2-thiobarbiturate--<i>N</i>,<i>N</i>-dimethylacetamide (1/2)
C4H7N4,C4H3N2O2S,2(C4H9NO)
Acta Crystallographica Section C (2016) 72, 9
a=9.8868(12)Å b=17.2380(14)Å c=12.8571(14)Å
α=90° β=88.151(9)° γ=90°
2,4-Diaminopyrimidinium 6-propyl-2-thiouracilate--2,4-diaminopyrimidine--<i>N</i>,<i>N</i>-dimethylacetamide--water (1/1/1/1)
C4H7N4,C7H9N2OS,C4H6N4,C4H9NO,H2O
Acta Crystallographica Section C (2016) 72, 8
a=7.9688(10)Å b=11.2412(15)Å c=14.6144(19)Å
α=109.442(10)° β=92.075(11)° γ=100.877(11)°
6-Methoxymethyl-2-thiouracil--<i>N</i>,<i>N</i>-dimethylformamide (1/1)
C6H8N2O2S,C3H7NO
Acta Crystallographica Section C (2016) 72, 8
a=7.2516(16)Å b=8.9841(17)Å c=10.736(2)Å
α=109.275(16)° β=109.132(17)° γ=97.283(17)°
6-Methoxymethyl-2-thiouracil--<i>N</i>,<i>N</i>-dimethylacetamide (1/1)
C6H8N2O2S,C4H9NO
Acta Crystallographica Section C (2016) 72, 8
a=8.2090(15)Å b=9.1804(17)Å c=9.5617(17)Å
α=65.128(14)° β=83.198(15)° γ=78.854(14)°
6-Methoxymethyl-2-thiouracil--dimethyl sulfoxide (1/1)
C6H8N2O2S,C2H6OS
Acta Crystallographica Section C (2016) 72, 8
a=8.1891(7)Å b=17.7131(13)Å c=8.3032(8)Å
α=90° β=94.643(8)° γ=90°
6-Methoxymethyl-2-thiouracil--1-methylpyrrolidin-2-one (1/1)
C6H8N2O2S,C5H9NO
Acta Crystallographica Section C (2016) 72, 8
a=6.7673(13)Å b=9.9189(15)Å c=10.4097(17)Å
α=82.868(13)° β=74.093(13)° γ=74.741(13)°
2,4,6-Triaminopyrimidinium 6-methoxymethyl-2-thiouracilate--6-methoxymethyl-2-thiouracil (1/1)
C4H8N5,C6H7N2O2S,C6H8N2O2S
Acta Crystallographica Section C (2016) 72, 8
a=6.8086(4)Å b=8.1414(5)Å c=18.6651(14)Å
α=90° β=90° γ=90°
C3H6N6,2(C5H9NO),H2O
C3H6N6,2(C5H9NO),H2O
Acta Crystallographica Section B (2015) 71, 2 209-220
a=7.6291(4)Å b=21.0118(8)Å c=10.9690(6)Å
α=90.00° β=98.950(4)° γ=90.00°
C4H3ClN2O2,C4H7N5,2(C5H9NO),H2O
C4H3ClN2O2,C4H7N5,2(C5H9NO),H2O
Acta Crystallographica Section B (2015) 71, 2 209-220
a=9.4450(6)Å b=10.3974(7)Å c=13.3661(8)Å
α=77.188(5)° β=89.846(5)° γ=67.043(5)°
C4H3ClN2O2,C4H7N5,C4H9NO
C4H3ClN2O2,C4H7N5,C4H9NO
Acta Crystallographica Section B (2015) 71, 2 209-220
a=6.9970(5)Å b=8.6140(5)Å c=13.8513(9)Å
α=85.725(5)° β=84.516(5)° γ=75.572(5)°
C4H3ClN2O2,C4H7N5,C3H7NO,H2O
C4H3ClN2O2,C4H7N5,C3H7NO,H2O
Acta Crystallographica Section B (2015) 71, 2 209-220
a=7.1719(11)Å b=8.6197(11)Å c=13.5029(19)Å
α=94.574(11)° β=92.707(12)° γ=99.840(11)°
C4H3ClN2O2,C3H4ClN5,C3H7NO
C4H3ClN2O2,C3H4ClN5,C3H7NO
Acta Crystallographica Section B (2015) 71, 2 209-220
a=8.4573(10)Å b=9.3488(10)Å c=10.8269(11)Å
α=72.144(8)° β=77.879(9)° γ=77.444(9)°
C4H3ClN2O2,C3H4ClN5,C3H7NO
C4H3ClN2O2,C3H4ClN5,C3H7NO
Acta Crystallographica Section B (2015) 71, 2 209-220
a=11.9691(7)Å b=12.3455(7)Å c=12.4618(7)Å
α=109.385(4)° β=96.199(5)° γ=111.598(4)°
C5H5ClN2O2,2(C3H6N6),C4H9NO,C2H7N,3(HCl)
C5H5ClN2O2,2(C3H6N6),C4H9NO,C2H7N,3(HCl)
Acta Crystallographica Section B (2015) 71, 2 209-220
a=18.6341(15)Å b=13.0507(10)Å c=12.3166(10)Å
α=90.00° β=101.365(7)° γ=90.00°
C5H5ClN2O2
C5H5ClN2O2
Acta Crystallographica Section B (2015) 71, 2 209-220
a=4.4135(6)Å b=15.780(3)Å c=9.0645(14)Å
α=90.00° β=92.025(12)° γ=90.00°
C4H4FN3O,C4H5N3
C4H4FN3O,C4H5N3
Acta Crystallographica Section B (2012) 68, 4 431-443
a=6.2414(12)Å b=7.2335(17)Å c=11.546(2)Å
α=105.371(18)° β=101.944(16)° γ=91.700(18)°
2(C4H4FN3O),C6H9N3O2
2(C4H4FN3O),C6H9N3O2
Acta Crystallographica Section B (2012) 68, 4 431-443
a=7.6548(12)Å b=9.3233(14)Å c=12.848(2)Å
α=83.406(12)° β=83.529(12)° γ=81.420(12)°
C4H4FN3O,C4H5N3O2
C4H4FN3O,C4H5N3O2
Acta Crystallographica Section B (2012) 68, 4 431-443
a=15.5508(15)Å b=11.7839(7)Å c=11.4971(12)Å
α=90.00° β=101.660(8)° γ=90.00°
C4H4FN3O,C4H6N4O,H2O
C4H4FN3O,C4H6N4O,H2O
Acta Crystallographica Section B (2012) 68, 4 431-443
a=8.3280(12)Å b=9.3484(14)Å c=9.4779(15)Å
α=61.797(11)° β=64.500(11)° γ=67.138(11)°
C4H4FN3O,C8H11N5O3
C4H4FN3O,C8H11N5O3
Acta Crystallographica Section B (2012) 68, 4 431-443
a=7.0859(5)Å b=9.0414(5)Å c=22.8754(16)Å
α=90.00° β=98.155(6)° γ=90.00°
C4H4FN3O,C2H5N3O2,C2H6OS
C4H4FN3O,C2H5N3O2,C2H6OS
Acta Crystallographica Section B (2012) 68, 4 444-452
a=8.4065(17)Å b=8.9045(18)Å c=10.6441(19)Å
α=111.163(15)° β=96.337(15)° γ=105.703(16)°
C4H4FN3O,C5H7N3O,H2O
C4H4FN3O,C5H7N3O,H2O
Acta Crystallographica Section B (2012) 68, 4 444-452
a=5.1193(8)Å b=9.3392(15)Å c=12.4862(19)Å
α=97.103(12)° β=93.662(13)° γ=95.766(13)°
C6H7N3O3
C6H7N3O3
Acta Crystallographica Section B (2012) 68, 4 444-452
a=11.4303(12)Å b=7.1695(8)Å c=8.9753(11)Å
α=90.00° β=102.194(9)° γ=90.00°
C6H9N3O2
C6H9N3O2
Acta Crystallographica Section B (2012) 68, 4 431-443
a=7.9835(14)Å b=10.0664(12)Å c=9.8380(16)Å
α=90.00° β=111.266(13)° γ=90.00°
C4H4FN3O,C6H7N3O3,C2H6OS
C4H4FN3O,C6H7N3O3,C2H6OS
Acta Crystallographica Section B (2012) 68, 4 444-452
a=9.4478(9)Å b=23.7171(16)Å c=7.2635(7)Å
α=90.00° β=96.700(8)° γ=90.00°
2(C4H4FN3O),2(C4H6N4O),C3H7NO
2(C4H4FN3O),2(C4H6N4O),C3H7NO
Acta Crystallographica Section B (2012) 68, 4 431-443
a=7.1894(12)Å b=10.0991(15)Å c=10.9953(19)Å
α=104.970(10)° β=105.330(10)° γ=110.850(10)°
2(C4H4FN3O),C4H6N4O,C3H7NO
2(C4H4FN3O),C4H6N4O,C3H7NO
Acta Crystallographica Section B (2012) 68, 4 431-443
a=11.2283(11)Å b=15.1837(12)Å c=18.8290(17)Å
α=71.262(7)° β=87.187(8)° γ=88.460(7)°
C5H7N3O,C4H6N4O,2(C4H9NO)
C5H7N3O,C4H6N4O,2(C4H9NO)
Acta Crystallographica Section B (2012) 68, 4 444-452
a=6.9824(11)Å b=9.1224(14)Å c=17.651(3)Å
α=88.329(12)° β=89.875(12)° γ=75.513(12)°
1-Benzoyl-2-(propan-2-ylidene)hydrazone
C10H12N2O
Acta crystallographica. Section C, Structural chemistry (2014) 70, Pt 9 912-919
a=7.6950(8)Å b=17.1290(10)Å c=7.8316(8)Å
α=90.00° β=115.525(8)° γ=90.00°
1-Benzoyl-2-[1-(naphthalen-2-yl)ethylidene]hydrazone
C19H16N2O
Acta crystallographica. Section C, Structural chemistry (2014) 70, Pt 9 912-919
a=5.5789(5)Å b=7.6868(9)Å c=33.128(3)Å
α=90.00° β=90.356(7)° γ=90.00°
1-Benzoyl-2-(1-cyclohexylethylidene)hydrazone
C15H20N2O
Acta crystallographica. Section C, Structural chemistry (2014) 70, Pt 9 912-919
a=9.3086(9)Å b=18.283(2)Å c=8.1543(7)Å
α=90.00° β=103.328(7)° γ=90.00°
1-Benzoyl-2-(1-cyclohexylbenzylidene)hydrazone
C20H22N2O
Acta crystallographica. Section C, Structural chemistry (2014) 70, Pt 9 912-919
a=16.0939(15)Å b=13.8666(8)Å c=16.8556(16)Å
α=90.00° β=116.661(7)° γ=90.00°
1-Benzoyl-2-(1-phenylbenzylidene)hydrazone
C20H16N2O
Acta crystallographica. Section C, Structural chemistry (2014) 70, Pt 9 912-919
a=16.8630(10)Å b=10.1678(8)Å c=18.694(2)Å
α=90.00° β=102.079(6)° γ=90.00°
1-Benzoyl-2-[1-(4-chlorophenyl)benzylidene]hydrazone
C20H15ClN2O
Acta crystallographica. Section C, Structural chemistry (2014) 70, Pt 9 912-919
a=19.432(4)Å b=8.9330(18)Å c=19.496(4)Å
α=90.00° β=102.18(3)° γ=90.00°
1-Benzoyl-2-(4-hydroxybenzylidene)hydrazone methanol monosolvate
C15H16N2O3
Acta crystallographica. Section C, Structural chemistry (2014) 70, Pt 9 912-919
a=13.3820(10)Å b=8.8183(8)Å c=23.275(2)Å
α=90.00° β=90.00° γ=90.00°
1-Benzoyl-2-(1,1-diphenylpropan-2-ylidene)hydrazone
C22H20N2O
Acta crystallographica. Section C, Structural chemistry (2014) 70, Pt 9 912-919
a=11.1869(8)Å b=7.9143(6)Å c=20.233(2)Å
α=90.00° β=92.967(6)° γ=90.00°
(3R,6S,1'R)-3-(1-Naphth-1-yl-2-nitro-ethyl)-6-isopropyl-2,5- dimethoxy-3,6-dihydro-pyrazine
C21H25N3O4
Acta Crystallographica Section C (1999) 55, 6 964-968
a=7.8880(10)Å b=8.6430(10)Å c=29.8320(10)Å
α=90.00° β=90.00° γ=90.00°
C19H27N3O6
C19H27N3O6
Acta Crystallographica Section C (1999) 55, 6 964-968
a=8.880(2)Å b=6.748(2)Å c=17.730(4)Å
α=90.00° β=100.42(3)° γ=90.00°
C14H24N2O4
C14H24N2O4
Acta Crystallographica Section C (1999) 55, 6 964-968
a=8.5140(10)Å b=9.3010(10)Å c=20.119(2)Å
α=90.00° β=90.00° γ=90.00°
(3R,6S)-3-[(R)-Hydroxy-phenyl-methyl]-6-isopropyl-2,5-dimethoxy- 3,6-dihydro-pyrazine
C16H22N2O3
Acta Crystallographica Section C (1999) 55, 6 964-968
a=8.2110(10)Å b=9.2540(10)Å c=20.861(2)Å
α=90.00° β=90.00° γ=90.00°
(3S,6S)-3,6-Dibenzyl-2,5-dimethoxy-3,6-dihydro-pyrazine
C20H22N2O2
Acta Crystallographica Section C (1999) 55, 6 968-973
a=10.9980(10)Å b=11.5130(10)Å c=14.4640(10)Å
α=90.00° β=90.00° γ=90.00°
(3R,6S)-3-Benzyl-6-(cyclohexyl-methyl)-2,5-dimethoxy- 3,6-dihydro-pyrazine
C20H28N2O2
Acta Crystallographica Section C (1999) 55, 6 968-973
a=6.4410(10)Å b=9.0360(10)Å c=32.996(4)Å
α=90.00° β=90.00° γ=90.00°
(3R,6S)-3-Benzyl-6-pentafluorophenyl-methyl-2,5-dimethoxy- 3,6-dihydro-pyrazine
C20H17F5N2O2
Acta Crystallographica Section C (1999) 55, 6 968-973
a=5.8800(10)Å b=7.4490(10)Å c=11.1970(10)Å
α=98.410(10)° β=90.130(10)° γ=91.970(10)°
C24H30N2O4
C24H30N2O4
Acta Crystallographica Section C (1999) 55, 6 968-973
a=6.8600(10)Å b=16.4610(10)Å c=20.386(2)Å
α=90.00° β=90.00° γ=90.00°
(3RS,6SR)-3,6-Dibenzyl-2,5-dimethoxy-3,6-dihydro-pyrazine
C20H22N2O2
Acta Crystallographica Section C (1999) 55, 6 968-973
a=5.8030(10)Å b=10.4860(10)Å c=14.7620(10)Å
α=90.00° β=90.050(10)° γ=90.00°
C26H29NO2
C26H29NO2
Acta Crystallographica Section C (1992) 48, 11 2035-2036
a=9.7770(10)Å b=10.2110(10)Å c=22.585(2)Å
α=90° β=90° γ=90°
C16H24O
C16H24O
Acta Crystallographica Section C (1992) 48, 11 2044-2045
a=15.960(10)Å b=5.339(5)Å c=16.97(2)Å
α=90° β=117.43(6)° γ=90°
2(C2H4F3N2),Cl8Mo2O2
2(C2H4F3N2),Cl8Mo2O2
Acta Crystallographica Section C (1992) 48, 10 1843-1844
a=6.7010(10)Å b=8.6740(10)Å c=9.1790(10)Å
α=83.500(10)° β=89.370(10)° γ=74.350(10)°
C27H28O12
C27H28O12
Acta Crystallographica Section C (1993) 49, 2 250-253
a=8.0290(10)Å b=8.2240(10)Å c=37.261(6)Å
α=90° β=90° γ=90°
C16H25NO4
C16H25NO4
Acta Crystallographica Section C (1996) 52, 9 2253-2254
a=6.806(1)Å b=8.166(1)Å c=15.568(2)Å
α=100.69(1)° β=94.99(2)° γ=103.29(1)°
C26H46Co2Mo2O22P6
C26H46Co2Mo2O22P6
Acta Crystallographica Section C (1996) 52, 9 2161-2164
a=13.651(1)Å b=23.910(3)Å c=27.883(2)Å
α=90° β=102.44(1)° γ=90°
C18H24O3
C18H24O3
Acta Crystallographica Section C (1996) 52, 9 2254-2256
a=13.734(2)Å b=8.281(1)Å c=6.530(1)Å
α=90° β=90° γ=90°
C14H17N1O3
C14H17N1O3
Acta Crystallographica Section C (1994) 50, 7 1117-1118
a=9.8730(10)Å b=6.1290(10)Å c=11.5940(10)Å
α=90.° β=108.230(10)° γ=90.°
6-Methyl-2-thiouracil--2,4-diaminopyrimidine--1-methylpyrrolidin-2-one (1/1/2)
C5H6N2OS,C4H6N4,2(C5H9NO)
Acta Crystallographica Section C (2015) 71, 3
a=13.9475(5)Å b=8.1618(3)Å c=40.9157(14)Å
α=90° β=98.148(3)° γ=90°
6-Methyl-2-thiouracil--2,4-diaminopyrimidine--dimethylformamide (2/1/2)
C5H6N2OS,0.5(C4H6N4),C3H7NO
Acta Crystallographica Section C (2015) 71, 3
a=14.9786(15)Å b=8.2010(11)Å c=22.568(2)Å
α=90° β=99.899(8)° γ=90°
6-Methyl-2-thiouracil--2,4-diaminopyrimidine--dimethylacetamide (2/1/2)
2(C5H6N2OS),C4H6N4,2(C4H9NO)
Acta Crystallographica Section C (2015) 71, 3
a=8.2095(7)Å b=12.8069(11)Å c=14.3391(13)Å
α=89.914(7)° β=76.230(7)° γ=83.418(7)°
6-Methyl-2-thiouracil--6-amino-3<i>H</i>-isocytosine--dimethylformamide (1/1/1)
C5H6N2OS,C4H6N4O,C3H7NO
Acta Crystallographica Section C (2015) 71, 3
a=7.3559(6)Å b=30.068(2)Å c=8.1263(7)Å
α=90° β=115.534(6)° γ=90°
6-Methyl-2-thiouracil--6-amino-3<i>H</i>-isocytosine--dimethyl sulfoxide (1/1/1)
C5H6N2OS,C4H6N4O,C2H6OS
Acta Crystallographica Section C (2015) 71, 3
a=8.2520(7)Å b=23.9532(19)Å c=8.2133(6)Å
α=90° β=102.496(6)° γ=90°
5-fluorocytosine dimethyl sulfoxide solvate
C4H4FN3O,C2H6OS
Acta Crystallographica Section C (2009) 65, 11 o574-o578
a=12.4467(12)Å b=9.1849(8)Å c=8.5635(8)Å
α=90.00° β=107.065(8)° γ=90.00°
5-fluorocytosine dimethylacetamide hemisolvate
C4H4FN3O,0.5C4H9NO
Acta Crystallographica Section C (2009) 65, 11 o574-o578
a=7.7247(12)Å b=8.2840(13)Å c=13.238(2)Å
α=90.204(13)° β=104.336(12)° γ=107.774(12)°
5-fluorocytosine hemihydrate
C4H4FN3O,0.5H2O
Acta Crystallographica Section C (2009) 65, 11 o574-o578
a=14.7039(13)Å b=12.4546(10)Å c=13.7921(14)Å
α=90.00° β=115.474(7)° γ=90.00°
Nitrofurantoin dimethyl sulfoxide monosolvate
C8H6N4O5,C2H6OS
Acta Crystallographica Section C (2011) 67, 1 o18-o25
a=6.6257(4)Å b=26.488(2)Å c=8.0032(5)Å
α=90.00° β=100.347(5)° γ=90.00°
Nitrofurantoin dimethylacetamide monosolvate
C8H6N4O5,C4H9NO
Acta Crystallographica Section C (2011) 67, 1 o18-o25
a=16.2038(16)Å b=7.4215(5)Å c=13.1195(12)Å
α=90.00° β=111.681(7)° γ=90.00°
2,6-diacetaminopyridine dimethylformamide monosolvate
C9H11N3O2,C3H7NO
Acta Crystallographica Section C (2011) 67, 1 o18-o25
a=11.3031(7)Å b=13.1539(8)Å c=9.3959(5)Å
α=90.00° β=94.327(5)° γ=90.00°
Nitrofurantoin dimethylacetamide disolvat
C8H6N4O5,2(C4H9NO)
Acta Crystallographica Section C (2011) 67, 1 o18-o25
a=20.874(2)Å b=11.5433(9)Å c=8.7162(9)Å
α=90.00° β=100.708(9)° γ=90.00°
Nitrofurantoin--2,6-diacetaminopyridine (1/1)
C8H6N4O5,C9H11N3O2
Acta Crystallographica Section C (2011) 67, 1 o18-o25
a=9.8407(6)Å b=17.9443(10)Å c=10.9902(6)Å
α=90.00° β=97.839(5)° γ=90.00°
Bicyclo[2.2.1]hept-2-ene-endo-cis-5,6-dicarboxylic anhydride
C9H8O3
Acta Crystallographica Section C (2000) 56, 11 1338-1342
a=5.926(2)Å b=9.489(3)Å c=13.452(5)Å
α=90° β=90° γ=90°
Bicyclo[2.2.1]hept-2-ene-endo-cis-5,6-dicarboxylic acid
C9H10O4
Acta Crystallographica Section C (2000) 56, 11 1338-1342
a=10.999(2)Å b=7.3890(10)Å c=10.410(2)Å
α=90° β=98.75(3)° γ=90°
1,2,3,4,7,7-hexachlorobicyclo[2.2.1]hept-2-ene-endo-cis-5,6-dicarboxylic acid
C9H4Cl6O4
Acta Crystallographica Section C (2000) 56, 11 1338-1342
a=7.4990(10)Å b=7.924(2)Å c=11.873(2)Å
α=90° β=101.650(10)° γ=90°
1,2,3,4,7,7-hexachlorobicyclo[2.2.1]hept-2-ene-endo-cis-5,6-dicarboxylic acid
C9H4Cl6O4
Acta Crystallographica Section C (2000) 56, 11 1338-1342
a=8.4430(10)Å b=24.8090(10)Å c=13.5940(10)Å
α=90° β=90.380(10)° γ=90°
1,2,3,4,7,7-hexachlorobicyclo[2.2.1]hept-2-ene-endo-cis-5,6-dicarboxylic anhydride diethyl ether solvate
C9H2Cl6O3,0.16(C4H10O)
Acta Crystallographica Section C (2000) 56, 11 1338-1342
a=29.639(4)Å b=29.639(4)Å c=8.119(2)Å
α=90° β=90° γ=120°
Ethyl 1,2,3,4,7,7-hexachloro-6-carboxybicyclo[2.2.1]hept-2-ene-endo-cis-5-carboxylate monohydrate
C11H8Cl6O4,H2O
Acta Crystallographica Section C (2000) 56, 11 1338-1342
a=8.616(3)Å b=9.281(2)Å c=10.460(4)Å
α=100.53(2)° β=94.00(2)° γ=95.06(2)°
C15H22O6
C15H22O6
Acta Crystallographica Section C (1994) 50, 11 1717-1721
a=7.5030(10)Å b=19.330(2)Å c=10.957(2)Å
α=90° β=102.91(2)° γ=90°
C12H12O4
C12H12O4
Acta Crystallographica Section C (1994) 50, 11 1717-1721
a=5.9950(10)Å b=9.0800(10)Å c=20.379(2)Å
α=90° β=90° γ=90°
C17H22O6
C17H22O6
Acta Crystallographica Section C (1994) 50, 11 1717-1721
a=11.4050(10)Å b=8.3540(10)Å c=17.1420(10)Å
α=90° β=90° γ=90°
C13H22O6
C13H22O6
Acta Crystallographica Section C (1994) 50, 11 1717-1721
a=10.8990(10)Å b=11.0560(10)Å c=12.174(2)Å
α=90° β=99.74(2)° γ=90°
Trimethoprim--3,3-dimethylglutarimide (1/1)
C14H18N4O3,C7H11NO2
Acta Crystallographica Section C (2015) 71, 1
a=7.361(2)Å b=12.032(2)Å c=14.132(3)Å
α=109.59(3)° β=92.48(3)° γ=99.14(3)°
Trimethoprim--glutarimide (1/1)
C14H18N4O3,C5H7NO2
Acta Crystallographica Section C (2015) 71, 1
a=8.774(2)Å b=17.046(3)Å c=14.168(3)Å
α=90.00° β=102.04(3)° γ=90.00°
Chelidamic acid methanol monosolvate
C7H5NO5,CH4O
Acta Crystallographica Section C (2012) 68, 9 o344-o350
a=5.8256(5)Å b=12.5648(12)Å c=12.7464(11)Å
α=90.00° β=100.303(7)° γ=90.00°
Chelidamic acid dimethyl ester monohydrate
C9H9NO5,H2O
Acta Crystallographica Section C (2012) 68, 9 o344-o350
a=17.241(3)Å b=6.1519(12)Å c=20.710(4)Å
α=90.00° β=107.96(3)° γ=90.00°
Dimethylammonium chelidamate
C2H8N,C7H4NO5
Acta Crystallographica Section C (2012) 68, 9 o344-o350
a=7.3688(8)Å b=11.1416(12)Å c=14.3584(15)Å
α=69.025(8)° β=79.438(9)° γ=72.455(9)°
Chelidamic acid dimethyl sulfoxide monosolvate
C7H5NO5,C2H6OS
Acta Crystallographica Section C (2012) 68, 9 o344-o350
a=4.7460(4)Å b=10.4917(9)Å c=11.9787(11)Å
α=103.592(7)° β=97.606(7)° γ=101.651(7)°
5,6-Dimethyl-2-thiouracil--dimethyl sulfoxide (2/1)
2(C6H8N2OS),C2H6OS
Acta Crystallographica Section C (2014) 70, 2 241-249
a=8.1597(14)Å b=22.612(3)Å c=10.5576(17)Å
α=90.00° β=105.459(13)° γ=90.00°
5-Methoxy-2-thiouracil
C5H6N2O2S
Acta Crystallographica Section C (2014) 70, 2 241-249
a=4.3141(6)Å b=16.9101(18)Å c=8.9965(12)Å
α=90.00° β=93.593(10)° γ=90.00°
5-Propyl-2-thiouracil
C7H10N2OS
Acta Crystallographica Section C (2014) 70, 2 241-249
a=8.6637(10)Å b=10.3098(13)Å c=10.7255(13)Å
α=76.253(10)° β=71.401(9)° γ=70.983(9)°
5,6-Dimethyl-2-thiouracil
C6H8N2OS
Acta Crystallographica Section C (2014) 70, 2 241-249
a=6.8295(10)Å b=15.2624(18)Å c=7.0948(11)Å
α=90.00° β=112.336(11)° γ=90.00°
5,6-Dimethyl-2-thiouracil--1-methylpyrrolidin-2-one (1/1)
C6H8N2OS,C5H9NO
Acta Crystallographica Section C (2014) 70, 2 241-249
a=15.2437(6)Å b=6.8275(17)Å c=23.555(2)Å
α=90.00° β=90.00° γ=90.00°
5,6-Dimethyl-2-thiouracil--dimethylformamide (2/1)
2(C6H8N2OS),(C3H7NO)
Acta Crystallographica Section C (2014) 70, 2 241-249
a=8.5895(13)Å b=8.6241(14)Å c=15.350(2)Å
α=100.404(13)° β=95.341(12)° γ=119.496(11)°
5,6-Dimethyl2-thiouracil--dimethylacetamide (2/1)
2(C6H8N2OS),C4H9NO
Acta Crystallographica Section C (2014) 70, 2 241-249
a=8.0876(14)Å b=11.1034(17)Å c=11.9115(17)Å
α=80.017(12)° β=70.979(12)° γ=75.575(13)°
2-aminopyrimidine--6-propyl-2-thiouracil (1/2)
C4H5N3,2(C7H10N2OS)
Acta Crystallographica Section C (2011) 67, 11 o439-o445
a=7.6094(5)Å b=12.9888(6)Å c=20.8838(14)Å
α=90.00° β=99.179(5)° γ=90.00°
6-propyl-2-thiouracil
C7H10N2OS
Acta Crystallographica Section C (2011) 67, 11 o439-o445
a=10.4340(6)Å b=11.1320(6)Å c=28.7090(17)Å
α=90.00° β=90.00° γ=90.00°
<i>N</i>-(6-acetamidopyridin-2-yl)acetamide--6-propyl-2-thiouracil (1/2)
C9H11N3O2,2(C7H10N2OS)
Acta Crystallographica Section C (2011) 67, 11 o439-o445
a=37.9355(12)Å b=76.880(3)Å c=10.5666(3)Å
α=90.00° β=90.00° γ=90.00°
2,4-Diaminopyrimidinium 6-methoxymethyl-2-thiouracilate
C4H7N4,C6H7N2O2S
Acta Crystallographica Section C (2016) 72, 8
a=4.6843(4)Å b=13.9818(19)Å c=19.5128(19)Å
α=90° β=91.450(8)° γ=90°